Finance

Lists
7EY:FRA
Kiora Pharmaceuticals Inc
0,00%
(0,00) 1D
4-окт., 23:46:04 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 7EY...
Mkt. cap
11,24 млн
Volume
0,00
52-wk high
0,42 €
52-wk low
0,42 €
No. of employees
13
Mkt. cap
11,24 млн
Volume
0,00
52-wk high
0,42 €
52-wk low
0,42 €
No. of employees
13
News stories
From web sources and news partners
About Kiora Pharmaceuticals Inc
CEO-
Employees13
Founded1998
HeadquartersЭнсинитас, Калифорния, Америка Кошмо Штаттары
SectorPharmaceutical industry
Websitekiorapharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
-
-
-
-
Cost of goods sold
1,07 млн
1,17 млн
890,50 миң
740,85 миң
Cost of revenue
1,07 млн
1,17 млн
890,50 миң
740,85 миң
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,44 млн
1,46 млн
1,61 млн
1,38 млн
Operating expense
1,44 млн
1,46 млн
1,61 млн
1,38 млн
Total operating expenses
2,52 млн
2,63 млн
2,50 млн
2,12 млн
Operating income
-2,52 млн
-2,63 млн
-2,50 млн
-2,12 млн
Other non operating income
-23,71 миң
173,24 миң
-47,13 миң
-11,47 миң
EBT including unusual items
-616,32 миң
-7,17 млн
-2,42 млн
-2,08 млн
EBT excluding unusual items
-2,34 млн
-2,49 млн
-2,41 млн
-1,99 млн
Income tax expense
-643,13 миң
-649,97 миң
-
-
Effective tax rate
104,35%
9,07%
-
-
Other operating expenses
-
-
-
-
Net income
26,81 миң
-6,52 млн
-2,42 млн
-2,08 млн
Net profit margin
-
-
-
-
Earnings per share
0,01
-
-
-
Interest and investment income
201,82 миң
190,31 миң
139,34 миң
146,23 миң
Interest expense
-
-19,96 миң
-
-
Net interest expenses
201,82 миң
170,35 миң
139,34 миң
146,23 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,50 млн
-2,62 млн
-2,49 млн
-2,11 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору